Latest Expert Opinions

Signal
Opinion
Expert
TOP PICK
TOP PICK
April 19, 2012
Biopharmaceutical company. Strong grower. One of the few biotech companies that is making money and growing strong margins. Margins are growing at 20%-25% long-term growth. Trading at 16X.
Celgene Corp (CELG-Q)
April 19, 2012
Biopharmaceutical company. Strong grower. One of the few biotech companies that is making money and growing strong margins. Margins are growing at 20%-25% long-term growth. Trading at 16X.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$78.590
Owned
Yes
TOP PICK
TOP PICK
April 19, 2012
Looking for a definite catalyst later this year because he is anticipating the split into 2 companies, snacks and North American groceries. Snacks will be the higher growth, which will really benefit from international growth. The other will give a much higher dividend. Trades at a 8% discount to its peers.
Looking for a definite catalyst later this year because he is anticipating the split into 2 companies, snacks and North American groceries. Snacks will be the higher growth, which will really benefit from international growth. The other will give a much higher dividend. Trades at a 8% discount to its peers.
Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$38.200
Owned
Yes